Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.

Optical coherence tomography as a means to characterize visual pathway involvement in multiple sclerosis

Open access
Wicki, Carla A., Hanson, James V.M., Schippling, Sven · 2018 · Current Opinion in Neurology

Abstract

Purpose of review: Optical coherence tomography (OCT) is a noninvasive in-vivo imaging tool that enables the quantification of the various retinal layer thicknesses. Given the frequent involvement of the visual pathway in multiple sclerosis, OCT has become an important tool in clinical practice, research and clinical trials. In this review, the role of OCT as a means to investigate visual pathway damage in multiple sclerosis is discussed. Recent findings: Evidence from recent OCT studies suggests that the peripapillary retinal nerve fibre layer (pRNFL) appears to be an ideal marker of axonal integrity, whereas the macular ganglion cell and inner plexiform layer (GCIP) thickness enables early detection of neuronal degeneration in multiple sclerosis. The thickness of the macular inner nuclear layer (INL) has been suggested as a biomarker for inflammatory disease activity and treatment response in multiple sclerosis. OCT parameters may also be used as an outcome measure in clinical trials evaluating the neuroprotective or regenerative potential of new treatments. Summary: OCT provides insights into multiple sclerosis beyond the visual pathway. It is capable of quantifying the major pathological hallmarks of the disease, specifically inflammation and neuroaxonal degeneration. OCT, therefore, has the potential to become another mainstay in the monitoring of multiple sclerosis patients.

Overview

Integrity signals

Registry

Crossref · 10.1097/wco.0000000000000604

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 80 references

Cited by

See all 17

Metadata

Authors
Wicki, C. A., Hanson, J. V. M., & Schippling, S.
Affiliations
  • ETH Zurich (CH)
  • University of Zurich (CH)
  • Neuroimmunology and Multiple Sclerosis Research, Department of Neurology
Corresponding author
Schippling, Sven
Venue
Current Opinion in Neurology
Published
2018-10
Volume
31
Issue
5
Pages
662-668
ISSN
  • 1350-7540 (ISSN-L)
  • 1473-6551
OpenAlex
W2885679903
Cited by
16
References
80
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2021: 3 · 2020: 4 · 2019: 1 · 2018: 1
FWCI
0.33
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Current Opinion in Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • National Science Foundation
  • Biogen
  • Teva Pharmaceutical Industries
  • Myelin Repair Foundation
  • Multiple Sclerosis Society
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Universität Zürich
  • Schweizerische Multiple Sklerose Gesellschaft
Topics
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
  • Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
  • Health Sciences › Medicine › Ophthalmology › Drug-Induced Ocular Toxicity
Keywords
optical coherence tomography, multiple sclerosis, visual pathway, peripapillary retinal nerve fiber layer, axonal degeneration, neurodegeneration, biomarkers, disease activity, treatment response, neuroprotection, retinal imaging
MeSH terms
Humans, Multiple Sclerosis, Visual Pathways, Tomography, Optical Coherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Optical coherence tomography as a means to characterize visual pathway involvement in multiple sclerosis. https://app.cochat.ai/papers/10.1097/wco.0000000000000604
The paper
Wicki, C. A., Hanson, J. V. M., & Schippling, S. (2018). Optical coherence tomography as a means to characterize visual pathway involvement in multiple sclerosis. Current Opinion in Neurology. https://doi.org/10.1097/wco.0000000000000604

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.